Featuring the ‘Companion to Shakespeare for open access research, Europe PubMed Central (PMC)begins to index preprints, and Projekt DEAL’s decision to abandon negotiations with Elsevier.
Looking at who should be responsible for monitoring open access, a blockchain-based start-up seeking to revolutionize scholarly publishing, and a new system for comparing researchers across disciplines.
The problem of bias, both subconscious and conscious, in medical research was a consistent theme through many of the talks delivered at Evidence Live this year. As the first post in a series on the talks from Evidence Live, this article will give an overview of what evidence based medicine actually is. In his session, … Continue reading Evidence Live – what is evidence-based medicine?
Featuring The Lancet’s preprint experiment, ASCO granting open access options to industry, and the 20 journals that were denied an impact factor.
Featuring a study defending double-blind peer review, what’s next in the campaign for preregistration, and trial disclosure rates in the pharmaceutical industry.
Featuring the cost of journal subscriptions for the UK’s top universities, the open access mandate on its way through the California legislature, and a look at clinical trial disclosure rates.
Featuring proposals for an EU open access research platform, a tribute to Professor Doug Altman, and the ramifications of preprinting medical research.
Featuring the peer reviewers accidentally re-animating the ideas of a 19th century biologist, the funders using open science to fight ebola and Kim Kardashian’s foray into academic publishing.
Featuring a space-age solution to data sharing in drug development, the digital maze for accessing papers online, and a spotlight on patient-oriented research.
Featuring the latest domino to fall in the row over open access publishing for universities, concerns about higher Article Processing Charges (APCs) for high-impact journals, and why medical publication professionals should engage with Open Science.